Understanding the rise in cardiovascular diseases in Africa: Harmonising H3Africa genomic epidemiological teams and tools

Cardiovascular Journal of Africa

Volumn 25, Issue 3, 2014, Pages 134-136

  Owolabi, Mayowa O ^a   Mensah, George A ^b   Kimmel, Paul L ^c   Adu, Dwomoa ^d   Ramsay, Michele ^e,f   Waddy, Salina P ^g   Ovbiagele, Bruce ^h   Rabadan Diehl, Cristina ^b   Rasooly, Rebekah ^c   Akarolo Anthony, Sally N ⁱ   Rotimi, Charles ^j  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d UNIVERSITY OF GHANA   (Ghana)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^h MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

more..

Author keywords

Africa; Cardiovascular diseases; Epidemiology; Genomics; H3Africa

Indexed keywords

AFRICA; AGE DISTRIBUTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; EPIDEMIOLOGICAL MONITORING; FATALITY; GENETIC ASSOCIATION; GENOMICS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; ONSET AGE; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK FACTOR; WORKSHOP; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; EDUCATION; GENETICS; SOUTH AFRICA;

AFRICA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; EDUCATION; GENOMICS; HUMANS; RISK FACTORS; SOUTH AFRICA;

EID: 84905003680     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2014-030     Document Type: Review

References (24)

1. World Health Organisation. Assessing national capacity for the prevention and control of non-communicable diseases: report of the 2010 global survey. Geneva: World Health Organisation; 2012.
2. Leeder S, Raymond S, Greenberg H, Liu H, Esson K. A Race against Time: The Challenge of Cardiovascular Disease in Developing Countries. New York: Trustees of Columbia University, 2004.
3. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2095-2128.
4. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2197-2223.
5. World Health Organization. Preventing Chronic Diseases: a Vital Investment. Geneva: World Health Organization, 2005.
6. Mensah GA. Epidemiology of stroke and high blood pressure in Africa. Heart 2008; 94(6): 697-705. (Pubitemid 351752297)
7. Mensah GA. Descriptive epidemiology of cardiovascular risk factors and diabetes in sub-Saharan Africa. Prog Cardiovasc Dis 2013; 56(3): 240-250.
8. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383(9913): 245-254.
9. Krishnamurthi R, Moran A, Forouzanfar MH, Bennet D, Mensah GA, et al. The global burden of haemorrhagic stroke - a summary of findings from the Global Burden of Diseases, Injuries and Risk Factors 2010 Study. Global Heart 2014; 9 (1): 101-106.
10. Owolabi MO. Taming the burgeoning stroke epidemic in Africa: stroke quadrangle to the rescue. West Ind Med J 2011; 60(4): 412-421.
11. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet 2009; 374(9693): 934-947.
12. Tollman SM, Kahn K, Sartorius B, Collinson MA, Clark SJ, Garenne ML. Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study. Lancet 2008; 372(9642): 893-901.
13. Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation 2011; 124(3): 314-323.
14. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104(22): 2746-2753. (Pubitemid 33108145)
15. Mensah GA. Introduction: progress in cardiovascular diseases and diabetes in Africa. Prog Cardiovasc Dis 2013; 56(3): 232-233.
16. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2224-2260.
17. Baumgartner-Parzer SM, Waldhausl WK. The endothelium as a metabolic and endocrine organ: its relation with insulin resistance. Exp Clin Endocrinol Diabetes 2001; 109(Suppl 2): S166-S179. (Pubitemid 32577580)
18. Frohlich ED. Mechanisms contributing to high blood pressure. Ann Intern Med 1983; 98(5 Pt 2): 709-714. (Pubitemid 13135250)
19. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 2007; 65(12 Pt 2): S140-S146.
20. Mensah GA. Endothelial Biomedicine: The Public Health Challenges and Opportunities. In: Aird WC (ed). Endothelial Biomedicine. Cambridge, UK: Cambridge University Press, 2007: 1807-1814.
21. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107(3): 499-511. (Pubitemid 36158056)
22. Futrakul N, Sridama V, Futrakul P. Microalbuminuria - a biomarker of renal microvascular disease. Ren Fail 2009; 31(2): 140-143.
23. Ochodnicky P, Henning RH, van Dokkum RP, de Zeeuw D. Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage. J Cardiovasc Pharmacol 2006; 47(Suppl 2): S151-S162. (Pubitemid 44620205)
24. Ovbiagele B. Microalbuminuria: risk factor and potential therapeutic target for stroke? J Neurol Sci 2008; 271(1-2): 21-28.